a PK
Generic Name: lopinavir/ritonavir
Pill imprint a PK has been identified as Kaletra 133.3 mg / 33.3 mg.
Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy.
Kaletra 133.3 mg / 33.3 mg is not subject to the Controlled Substances Act.
See also related documents.
Kaletra Images
- Generic Name:
- lopinavir/ritonavir
- Imprint:
-
a PK
- Strength:
- 133.3 mg / 33.3 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-3959
Advertisement
More Kaletra resources
- Kaletra
- Kaletra (Wolters Kluwer)
- Kaletra Capsules (Wolters Kluwer)
- Kaletra Solution (Wolters Kluwer)
- Kaletra (Cerner Multum)
- Kaletra (Micromedex) - Includes Dosage Information
- Kaletra (AHFS DI)
- Kaletra (FDA)
- Kaletra Oral Solution (FDA)
Search Again
